SWS Hemodialysis Care Future Growth
Future criteria checks 5/6
SWS Hemodialysis Care is forecast to grow earnings and revenue by 42.4% and 33.2% per annum respectively. EPS is expected to grow by 41.9% per annum. Return on equity is forecast to be 12.4% in 3 years.
Key information
42.4%
Earnings growth rate
41.9%
EPS growth rate
Medical Equipment earnings growth | 26.5% |
Revenue growth rate | 33.2% |
Future return on equity | 12.4% |
Analyst coverage | Low |
Last updated | 19 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,216 | 300 | N/A | 192 | 1 |
12/31/2025 | 939 | 230 | N/A | 236 | 1 |
12/31/2024 | 719 | 188 | N/A | 120 | 1 |
9/30/2024 | 532 | 75 | 107 | 232 | N/A |
6/30/2024 | 573 | 106 | -26 | 89 | N/A |
3/31/2024 | 659 | 154 | -101 | 15 | N/A |
12/31/2023 | 690 | 194 | -48 | 65 | N/A |
9/30/2023 | 698 | 207 | 89 | 102 | N/A |
6/30/2023 | 623 | 176 | 233 | 245 | N/A |
3/31/2023 | 508 | 126 | 292 | 302 | N/A |
12/31/2022 | 382 | 59 | 233 | 246 | N/A |
9/30/2022 | 353 | 50 | 49 | 66 | N/A |
6/30/2022 | 305 | 33 | 26 | 47 | N/A |
3/31/2022 | 284 | 25 | 6 | 32 | N/A |
12/31/2021 | 283 | 19 | 5 | 33 | N/A |
12/31/2020 | 254 | 21 | -42 | -19 | N/A |
12/31/2019 | 142 | -34 | -38 | -11 | N/A |
12/31/2018 | 114 | -27 | -67 | -17 | N/A |
6/30/2018 | 105 | -7 | N/A | -17 | N/A |
3/31/2018 | 94 | -10 | N/A | -8 | N/A |
12/31/2017 | 85 | -4 | N/A | -14 | N/A |
9/30/2017 | 87 | 0 | N/A | -12 | N/A |
6/30/2017 | 88 | 4 | N/A | -10 | N/A |
3/31/2017 | 86 | 5 | N/A | -17 | N/A |
12/31/2016 | 87 | 5 | N/A | -5 | N/A |
9/30/2016 | 76 | 2 | N/A | -7 | N/A |
6/30/2016 | 66 | 0 | N/A | -8 | N/A |
3/31/2016 | 61 | 1 | N/A | -4 | N/A |
12/31/2015 | 57 | 2 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688410's forecast earnings growth (42.4% per year) is above the savings rate (2.8%).
Earnings vs Market: 688410's earnings (42.4% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688410's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688410's revenue (33.2% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688410's revenue (33.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688410's Return on Equity is forecast to be low in 3 years time (12.4%).